Thymic FDG Uptake in Children with Malignant Lesions Before First Therapy (Group Ia)
| Patient no. | Diagnosis | Age (y) | Maximum SUV in thymus |
|---|---|---|---|
| 1 | PNET | 5 | 1.05 |
| 2 | PNET | 8 | 0.98 |
| 3 | Ewing’s sarcoma | 8 | 2.84 |
| 4 | Ewing’s sarcoma | 8 | 2.41 |
| 5 | Ewing’s sarcoma | 9 | 2.40 |
| 6 | Ewing’s sarcoma | 10 | 1.76 |
| 7 | Non-Hodgkin’s lymphoma | 12 | NVU |
| 8 | Hodgkin’s disease | 12 | 2.74 |
| 9 | Osteosarcoma | 13 | 1.80 |
| 10 | Neurofibrosarcoma | 15 | 1.50 |
| 11 | Non-Hodgkin’s lymphoma | 15 | NVU |
| 12 | PNET | 15 | 1.73 |
| 13 | Ewing’s sarcoma | 16 | 1.03 |
| 14 | Neurofibrosarcoma | 16 | NVU |
| 15 | Teratocarcinoma | 17 | NVU |
SUV = standard uptake value; PNET = peripheral neuroectodermal tumor; NVU = no visible uptake of FDG.